<dl id="ilis8"></dl><strike id="ilis8"><option id="ilis8"><em id="ilis8"></em></option></strike>
<cite id="ilis8"><option id="ilis8"></option></cite>
    1. <ul id="ilis8"></ul>
  1. <blockquote id="ilis8"><strong id="ilis8"></strong></blockquote>
    歡迎光臨:萊耀標(biāo)準(zhǔn)品網(wǎng)!
    ?您的位置:對照品 > 對照品 > 工作對照品 >
    4,5-Dichloro-1,3-benzenedisulfonyl Dichloride-13C6
    產(chǎn)品基本信息
    產(chǎn)品編號:D437312
    產(chǎn)品名稱:4,5-Dichloro-1,3-benzenedisulfonyl Dichloride-13C6
    產(chǎn)品CAS:
    規(guī)格含量:2.5mg
    產(chǎn)品價格:面議
    聯(lián)系我們:
    產(chǎn)品詳細(xì)介紹
    標(biāo)準(zhǔn)品編號: D437312
    名稱: 4,5-Dichloro-1,3-benzenedisulfonyl Dichloride-13C6
    別名: 1,2-Dichlorobenzene-3,5-disulfonyl Chloride-13C6; 1,2-Dichlorobenzene-4,6-disulfonyl Chloride-13C6; 4,5-Dichloro-m-benzenedisulfonyl Chloride-13C6;
    參考CAS號: 70269-54-4
    分子式: ¹³C?H?Cl?O?S?
    分子量: 349.98
    種類: Standards; Isotopic Labeled Analogues;
    應(yīng)用: 4,5-Dichloro-1,3-benzenedisulfonyl Dichloride-13C6 is an intermediate used in the synthesis of Diclofenamide-13C6 (D436532), which is the labeled form of Diclofenamide, a potent carbonic anhydrase inhibitor. Diclofenamide may provide a therapeutic strategy in the inhibition of the human cytosolic isoforms I and II and transmembrane tumor-associated isoenzymes IX and XII. Diclofenamide has been shown to be is effective in the prevention of episodic weakness in both hypokalemic periodic paralysis (HypoPP) and potassium-sensitive periodic paralysis (PSPP).
    參考文獻


    2011-2018 信陽萊耀生物科技有限公司 @ 信陽埃爾文生物科技有限公司版權(quán)所有

    中檢所標(biāo)準(zhǔn)品,對照品,標(biāo)準(zhǔn)氣體
    Keywords: 中檢所標(biāo)準(zhǔn)品 對照品 標(biāo)準(zhǔn)氣體
    <dl id="ilis8"></dl><strike id="ilis8"><option id="ilis8"><em id="ilis8"></em></option></strike>
    <cite id="ilis8"><option id="ilis8"></option></cite>
      1. <ul id="ilis8"></ul>
    1. <blockquote id="ilis8"><strong id="ilis8"></strong></blockquote>
      欧美成人三级网站 | 欧美性猛交XXXXX乱大交3免费 | 多人性战交疯狂派对k8电影 | 久草国际 | 免费一区二区 |